布菲伊伊申配方的有效成分兼容性通过调节GSK3β介导的NLRP3炎症酶激活来缓解慢性阻塞性肺病炎症

Yanqin Qin1, Jiena Zhai2, Jingfan Yang2

  • 1Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China; Co-construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan and Education Ministry of P.R. China, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China; Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China.

概括

布菲·伊申配方 (ECC-BYF) 的有效成分兼容性通过抑制GSK3β介导的NLRP3炎症酶激活来降低慢性阻塞性肺病 (COPD) 炎症. 这项研究阐明了ECC-BYF在COPD中的抗炎机制.